# Latanoprost Versus Tafluprost: 24-hour Intraocular Pressure (IOP)

> **NCT01162603** · PHASE4 · COMPLETED · sponsor: **Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia** · enrollment: 40 (actual)

## Conditions studied

- Primary Open Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DEVICE:** Goldmann and Perkins applanation tonometry
- **DRUG:** TAFLUPROST 0.0015% EYEDROPS
- **DRUG:** LATANOPROST 0.005% EYEDROPS

## Key facts

- **NCT ID:** NCT01162603
- **Lead sponsor:** Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2013-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01162603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01162603, "Latanoprost Versus Tafluprost: 24-hour Intraocular Pressure (IOP)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01162603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*